baseclick GmbH

baseclick GmbH, based in Neuried near Munich, is a leading biotechnological company and was founded in 2008 as a spin out of the Ludwig Maximilian University of Munich by Dr. Thomas Carell. The basis of baseclick’s foundation is "Click Chemistry," discovered by the Nobel laureate in chemistry Dr. Barry Sharpless. The technology is used in many products, such as EdU cell proliferation kits, modifications of oligonucleotides, labeling of nucleotides for the "Next Generation Sequencing" (NGS) method, NGS diagnostic applications and the development of RNA-based drugs, among other things. Since April 2020, baseclick has initiated a COVID-19 vaccine development based on a click chemistry sugar-modified mRNA. baseclick GmbH has out-licensed this technology to numerous leading companies worldwide.